LifeMine Therapeutics Inc. raises $263 million in a funding round to accelerate the clinical development of LIFE-001 and advance its pipeline.
Amount Raised
$263 Million
Round Type
Venture
CambridgeBiotechnologyHealthcareTherapeuticsBiopharmaInvestors
Description
LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company, announced $263 million in financing. The funding will be used to accelerate the clinical development of their lead program, LIFE-001. This program is designed to transform organ transplantation. The financing will also help advance their pipeline of novel transplantation and immunology therapies.
Quick answer
LifeMine Therapeutics raised $263 Million in a funding round, dated August 6, 2026. Investors: ARCH Venture Partners, Gsk, RA Capital Management, Gates Frontier, Bezos Expeditions and Milky Way Investments. LifeMine Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did LifeMine Therapeutics raise?
- LifeMine Therapeutics raised $263 Million in a funding round on August 6, 2026.
- Who invested in LifeMine Therapeutics?
- ARCH Venture Partners, Gsk, RA Capital Management, Gates Frontier, Bezos Expeditions and Milky Way Investments are named as investors in this round.
- What does LifeMine Therapeutics do?
- LifeMine Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™.
- Where is LifeMine Therapeutics based and how big is it?
- LifeMine Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 51 employees.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as LifeMine Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tempest Therapeutics raised $7.5M on September 15, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Os Therapies raised $5M on August 10, 2026.
- Os Therapies raised $1.6M on June 30, 2026.
- One04 Therapeutics GmbH & KG raised an undisclosed amount on September 15, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
Who to call at LifeMine Therapeutics, and when
A new round usually means LifeMine Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LifeMine Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LifeMine Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LifeMine Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LifeMine Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LifeMine Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.